药物停用试验的分型:方法学推荐
该文针对多重用药背景下药物停用临床推荐需求增加的问题,提出药物停用试验(DDT)的研究目标新分型及对应方法学推荐。通过多阶段开发流程(含文献检索和专家组),识别出三类不确定性并推导出三种研究类型,为每类研究制定了具体方法学建议。该分型有助于研究者明确研究目标与设计,提升未来药物停用试验质量。
要点
- 仅在存在科学不确定性时才需要开展临床试验。
- 药物停用相关不确定性分为三类,对应三种研究类型。
- 每种研究类型均有特定的方法学推荐。
核心结论
- 提出了药物停用试验研究目标、研究设计和方法的综合定义与推荐。
- 该分型可帮助研究者明确研究目标与研究设计。
- 类型特异的方法学推荐有望改善未来药物停用试验的质量。
研究设计与样本
- 多阶段开发流程,包括文献检索和专家组。
主要发现
- 仅在存在科学不确定性时才需要临床试验。
- 识别出与药物停用相关的三类不确定性并推导出三种研究类型。
- 第一种:对药物有效性和/或安全性的不确定性。
- 第二种:对停用已用药物程序的不确定性。
- 第三种:对停用一种或多种药物的复杂策略有效性的不确定性。
关键数值与推荐
- 为每种研究类型制定了特定的方法学推荐。
临床怎么用
- 研究者可依据该分型明确药物停用试验的研究目标并选择相应设计。
- 应参照类型特异的方法学推荐开展药物停用试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Due to the increasing concerns about polypharmacy, there is a growing need for clinical recommendations for drug discontinuation. This requires studies investigating the process on several levels. This paper addresses the methodological problems of drug discontinuation trials (DDTs). To that end, we offer a new typology of research aims and corresponding methodological recommendations for trials evaluating drug discontinuation. STUDY DESIGN AND SETTING: Multi-stage development process, including literature search and expert panels. RESULTS: Clinical trials are only required in cases of scientific uncertainty. We identified three situations of uncertainty associated with drug discontinuation from which we derived three study types: 1) Uncertainty regarding the effectiveness and/or safety of a drug; 2) Uncertainty regarding the procedure of discontinuing a previously taken drug; 3) Uncertainty regarding the effectiveness of complex strategies used to discontinue one or more drugs. We developed specific methodological recommendations for each study type. CONCLUSION: We offer a comprehensive definition of research aims, study designs, and methodological recommendations regarding DDTs. The typology we propose can help investigators clarify their research aims and study design. The type-specific methodological recommendation should improve the quality of future drug discontinuation trials.
引用
- Viniol A, Haasenritter J, Grede N, et al. Typology of drug discontinuation trials - Methodological recommendations. J Clin Epidemiol. 2021. PMID: 33775810. doi:10.1016/j.jclinepi.2021.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。